Based on the pharmacodynamic properties and the adverse events profile, it is unlikely that pariet would cause an impairment of driving performance or compromise the ability to use machinery. Read More →
During selection of first-line treatment options for pediatric schizophrenia and bipolar i disorder, consider the increased potential for pediatric patients to experience weight gain and elevated cholesterol or triglyceride concentrations from olanzapine treatment. Read More →
Burns jw order npxl 30 caps amex, loecker th, fischer jr jr, bauer dh 1996 rheumatol suppl 27 42-43 prevalence and significance of spinal disc abnormalities in an 5. Read More →